MK-4’s short half-life creates a different challenge — even at large doses, blood levels rise sharply after each dose and then fall quickly. This on-off pattern may explain why MK-4 studies used three-times-daily dosing at pharmacological amounts.
The much lower doses found in typical US supplements (45–100 mcg of MK-4) are unlikely to produce the same bone or cardiovascular effects seen in those Japanese research trials.
For older adults managing multiple supplements and medications, once-daily dosing is also a practical advantage. Simplicity supports consistency — and consistent K2 supplementation is what produces clinical results over months and years.
Bone Health: Which Form Has Better Evidence?
The strongest real-world evidence for MK-7 at standard supplemental doses comes from a three-year randomized controlled trial published in Osteoporosis International. Postmenopausal women who took 180 mcg of MK-7 daily showed significantly less bone density loss in the lumbar spine and femoral neck compared to the placebo group. The study also found that bone strength markers improved with MK-7 — meaning the bones were less brittle, not just denser.
MK-4 does have clinical trial data on bone health — but from Japanese studies using 1,000–1,500 mcg per day, pharmacological doses that are 10–15 times higher than what standard US supplements provide. Extrapolating those results to the 45–100 mcg MK-4 doses in most US capsules is not scientifically supported.
For a senior reading this: if your supplement label says “MK-4” and lists a dose below 500 mcg, the bone health evidence from Japanese trials does not apply to your supplement. MK-7 at 90–180 mcg has the clinical backing that low-dose MK-4 lacks.
MK-7 vs. MK-4: Which Form of Vitamin K2 Is Best for Bone Health?
If you have looked at vitamin K2 supplements recently, you have probably seen two forms listed on labels: MK-7 and MK-4. Both are vitamin K2. Both activate the same bone- and artery-protecting proteins. But they behave very differently inside the body.
For seniors choosing a K2 supplement, the distinction matters. The form determines how often you need to take it, what dose is effective, and which has stronger research behind it at the doses available in US supplements.
The short answer is that MK-7 is the better practical choice for most older adults. But understanding why helps you make a more informed decision — and ask better questions when you talk to your doctor.
Quick Answer
MK-7 stays active in the body for up to 72 hours and is effective at once-daily doses of 90–180 mcg — the doses found in standard US supplements. MK-4 has a half-life of just a few hours and requires doses of 1,000–1,500 mcg per day (split across three doses) to match the results seen in clinical trials. For most seniors, MK-7 is the preferred form for daily supplementation. Seniors on warfarin must consult their doctor before taking either form.
What Are MK-7 and MK-4?
Vitamin K2 is the family name for a group of fat-soluble vitamins called menaquinones, and the number after “MK” refers to the length of the molecule’s side chain — MK-4 has a shorter chain, MK-7 has a longer one. That structural difference drives the major differences in how long each form stays active in the body.
Both forms activate the same two critical proteins: osteocalcin (which pulls calcium into bone) and matrix GLA protein (which prevents calcium from accumulating in artery walls). The question is not which protein they activate — it is which form delivers enough active K2 consistently enough to make a clinical difference at everyday supplement doses.
MK-7 vs. MK-4: The Key Differences
- Half-life: MK-7 stays active ~72 hours. MK-4 stays active only 4–6 hours.
- Effective daily dose: MK-7 works at 90–180 mcg/day. MK-4 requires 1,000–1,500 mcg/day.
- Dosing frequency: MK-7 = once daily. MK-4 = three times per day at pharmacological doses.
- Primary food source: MK-7 comes from natto and fermented foods. MK-4 is found in animal products (chicken liver, egg yolk, butter).
- US supplement availability: Most K2 supplements sold in the US use MK-7.
- Research at standard doses: MK-7 has strong bone and cardiovascular evidence at 90–180 mcg. MK-4’s landmark bone trials used pharmacological doses not available in standard US supplements.
Why Half-Life Matters for Seniors
A longer half-life means consistent, stable blood levels throughout the day — which is exactly what you need for a fat-soluble vitamin that works by activating proteins involved in ongoing calcium metabolism. With MK-7’s 72-hour half-life, a single daily dose maintains K2 activity through the entire day and into the next.
MK-4’s short half-life creates a different challenge — even at large doses, blood levels rise sharply after each dose and then fall quickly. This on-off pattern may explain why MK-4 studies used three-times-daily dosing at pharmacological amounts.
The much lower doses found in typical US supplements (45–100 mcg of MK-4) are unlikely to produce the same bone or cardiovascular effects seen in those Japanese research trials.
For older adults managing multiple supplements and medications, once-daily dosing is also a practical advantage. Simplicity supports consistency — and consistent K2 supplementation is what produces clinical results over months and years.
Bone Health: Which Form Has Better Evidence?
The strongest real-world evidence for MK-7 at standard supplemental doses comes from a three-year randomized controlled trial published in Osteoporosis International. Postmenopausal women who took 180 mcg of MK-7 daily showed significantly less bone density loss in the lumbar spine and femoral neck compared to the placebo group. The study also found that bone strength markers improved with MK-7 — meaning the bones were less brittle, not just denser.
MK-4 does have clinical trial data on bone health — but from Japanese studies using 1,000–1,500 mcg per day, pharmacological doses that are 10–15 times higher than what standard US supplements provide. Extrapolating those results to the 45–100 mcg MK-4 doses in most US capsules is not scientifically supported.
For a senior reading this: if your supplement label says “MK-4” and lists a dose below 500 mcg, the bone health evidence from Japanese trials does not apply to your supplement. MK-7 at 90–180 mcg has the clinical backing that low-dose MK-4 lacks.
This is one reason most physicians and dietitians who recommend K2 for bone health now specify the MK-7 form. You can find more on how K2 activates bone proteins in our detailed guide to vitamin K2 for seniors.
Heart and Artery Health: MK-7 vs. MK-4
The Rotterdam Study — one of the landmark studies on K2 and cardiovascular health — measured total dietary K2 intake, which includes all menaquinone forms. The 57% reduction in cardiovascular mortality was associated with higher overall K2 intake, not a specific form. However, since most K2 in the Western diet comes from fermented foods (primarily MK-7 sources), the cardiovascular evidence skews toward MK-7.
More recent trials have specifically studied MK-7 supplementation and arterial stiffness — a direct measure of artery health. A 2015 trial found that 180 mcg of MK-7 daily for three years significantly reduced arterial stiffness in healthy postmenopausal women. No comparable arterial stiffness trials exist for MK-4 at standard supplement doses.
Dosage: MK-7 vs. MK-4 for Seniors
For MK-7, the dose range used in clinical trials is 90–180 mcg per day. Both ends of this range have demonstrated measurable effects — 90 mcg on arterial stiffness, 180 mcg on bone density in the Knapen trial. Starting at 100 mcg and building to 180 mcg if tolerated is a reasonable approach for most seniors.
For MK-4, effective supplemental dosing requires 1,000–1,500 mcg per day divided across three meals. This is only available in specialty or prescription formulations — not in standard US health food store supplements. If a product lists “MK-4” at under 500 mcg, the dose is not clinically supported by bone health research. Seniors seeking evidence-backed supplementation should look specifically for MK-7.
Understanding how supplement absorption changes after 60 is relevant here too — fat-soluble vitamins including K2 may need slightly higher doses in older adults due to reduced fat digestion efficiency. Always take MK-7 with a fat-containing meal to maximize absorption.
Food Sources for MK-7 and MK-4
MK-7 foods: natto (fermented soybeans — the richest source at ~1,000 mcg per 100g), hard aged cheeses like Gouda and Edam, and some fermented dairy products. Most Western seniors do not eat natto regularly, making MK-7 supplementation the most practical route to meaningful K2 intake.
MK-4 foods: chicken liver, egg yolk, butter from grass-fed cows, and some cheeses. These foods provide MK-4 at very low amounts — typically 1–15 mcg per serving. While useful for background dietary K2, these amounts are far below the 1,000+ mcg per day needed to replicate the Japanese clinical trial results.
What a Doctor Will Typically Check
There is no routine clinical blood test for K2 status in standard US healthcare. Your doctor may measure undercarboxylated osteocalcin (ucOC) or uncarboxylated matrix GLA protein (ucMGP) in specialized settings — both are markers of K2 sufficiency — but these are research tools rather than standard labs.
More practically, bone density (DEXA scan) and coronary artery calcium scoring are the outcomes most directly influenced by long-term K2 status. If you have been supplementing with K2 for 12+ months and your doctor orders a repeat DEXA scan, improved or maintained bone density may reflect K2’s contribution alongside your other bone health measures.
Caregivers: if you are helping an older parent choose a K2 supplement, bring the label to their next appointment. Confirm the form (MK-7 or MK-4), the dose, and whether the prescribing doctor has cleared K2 given any anticoagulant use. A K2 and D3 combination supplement simplifies the routine and ensures both nutrients are taken together as intended.
Safety and Drug Interactions
Warfarin and anticoagulants: Both MK-7 and MK-4 can interact with warfarin — but MK-7’s longer half-life means its interaction is more sustained and consistent. For seniors on warfarin, MK-7’s stable blood levels actually make its interaction more predictable than MK-4’s spiky peak-and-trough pattern. Either way, do not start any form of K2 without first consulting your prescribing doctor.
Side effects: Both forms are well tolerated at standard doses. Mild digestive discomfort when starting is occasionally reported. Neither form carries a risk of K2 toxicity at supplemental doses — vitamin K does not accumulate in tissue the way vitamins A and D can at high levels.
Combination supplements: Many K2 products combine MK-4 and MK-7 in the same capsule. The rationale is that MK-4 provides the quick initial rise while MK-7 maintains longer-term levels. If your supplement uses this approach, verify the MK-7 dose is at least 90 mcg to ensure clinical effectiveness regardless of the MK-4 dose.
Frequently Asked Questions
What is the difference between vitamin K2 MK-7 and MK-4?
The main difference is how long each form stays active in the body. MK-7 has a half-life of approximately 72 hours, allowing once-daily dosing at 90–180 mcg with consistent blood levels. MK-4 has a half-life of 4–6 hours and requires pharmacological doses of 1,000–1,500 mcg per day divided across meals to achieve the effects seen in clinical trials — doses far above what most US supplements provide.
Which form of vitamin K2 is best for seniors?
MK-7 is the better practical choice for most older adults. It works at lower once-daily doses, has strong clinical trial evidence at those doses, and provides sustained blood levels throughout the day. MK-4 has legitimate clinical data behind it — but only at high pharmacological doses that are not commonly available in standard retail supplements.
What are the side effects of vitamin K2 MK-7?
MK-7 at 90–180 mcg is generally well tolerated. The most common reported side effect is mild digestive discomfort when first starting — this typically resolves within a week. The most significant risk is for seniors on warfarin or other anticoagulants, where MK-7 can affect medication effectiveness. At standard doses, MK-7 does not accumulate to toxic levels.
What foods have vitamin K2 MK-7?
Natto (fermented soybeans) is the richest dietary source of MK-7 by far, containing up to 1,000 mcg per 100g. Hard aged cheeses like Gouda and some fermented dairy products contain smaller amounts. Most seniors in the US do not eat natto regularly, making supplementation the most reliable way to achieve meaningful MK-7 intake.
What is the best time to take vitamin K2 MK-7?
Take MK-7 with a meal that contains fat — both for absorption and to reduce any risk of digestive discomfort. Morning or lunchtime works well. If you also take vitamin D3, take both at the same meal — they are both fat-soluble and work together on calcium metabolism, so co-administration is appropriate.
Can you take too much vitamin K2 MK-7?
At standard supplemental doses of 90–180 mcg, there is no established toxicity risk for MK-7. Unlike vitamins A and D, vitamin K2 does not accumulate in fatty tissue to dangerous levels. Very high doses have been used in research without toxicity. The primary risk at any dose is the interaction with warfarin — not toxicity from the K2 itself.
I manage my parent’s supplements. Should they take MK-7 or MK-4?
For most older adults, MK-7 is the right choice — it works at practical once-daily doses, has the strongest clinical evidence at those doses, and simplifies the supplement routine. Before purchasing, confirm the label says “MK-7” (not just “vitamin K2”), check the dose is at least 90 mcg, and ensure your parent is not on warfarin or any other anticoagulant before starting.
Final Thoughts for Adults Over 50
If you are choosing a vitamin K2 supplement for bone health or artery protection, the form matters as much as the dose. MK-7 at 90–180 mcg once daily has the clinical evidence, the practical dosing advantage, and the sustained blood levels that make supplementation consistent and effective.
If your current supplement says “MK-4” at a dose below 500 mcg, the evidence from clinical trials does not support that dose for bone health outcomes. Switching to an MK-7 supplement — or a combination product that includes at least 90 mcg of MK-7 — is a practical upgrade.
If you are a caregiver helping manage a parent’s supplement routine, check the K2 label and confirm the form and dose. Then bring it to the next appointment if they are on any blood thinner. Small details like this make a meaningful difference in long-term bone and cardiovascular health outcomes.
Sources
- NIH Office of Dietary Supplements — Vitamin K Fact Sheet for Health Professionals
- Knapen et al. (2013) — Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International.
- Geleijnse et al. (2004) — Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study. Journal of Nutrition.
- Knapen et al. (2015) — Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thrombosis and Haemostasis.
- Mayo Clinic — Vitamin K: Overview, Uses, and Side Effects
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider before starting any new supplement, especially if you take prescription medications, have a chronic health condition, or are managing anticoagulant therapy. Never disregard professional medical advice based on something you have read online.
You Might Also Be Wondering
- How much vitamin D seniors actually need — and when it becomes too much
- Warning signs seniors should never ignore
- CoQ10 for seniors: who needs it, what dose, and what to expect
